Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, we've committed to a 40% reduction in absolute Scope 1 and 2 emissions by 2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Diversity, Equity, and Inclusion (DEI) is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
CSL Behring teams with acclaimed photographer Rankin on an exhibition featuring portraits that chronicle life with hemophilia…
Annual grants support research into coagulation, thrombosis and acquired bleeding disorders.
CSL Behring’s Dr. Greg Kato will present to both patients and fellow researchers at this weekend’s 16th Annual Sickle Cell Di…
Wood, a CSL Plasma employee in Georgia, lives with primary immunodeficiency and depends on plasma-derived medicine.
New brand anthem film recognized alongside entries from the Smithsonian, Microsoft, ESPN and others.
The Beats Music Program from the Coalition for Hemophilia B brings patients together for a weekend of music training and perf…
In a Q&A with RARE Revolution magazine, CSL Behring’s Camilla Shen explains why demand is high: More patients are getting dia…
CSL Behring will sponsor free training in artificial intelligence for high school students in Philadelphia and Los Angeles.
This category of medical treatments comes from living organisms, including plants, animals and microorganisms – and can be ma…
Americas
Asia Pacific
Middle East
Europe